Related Experiment Video
Updated: Sep 24, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Invasive Fungal Pneumonia in Immunocompromised Patients
Myrna C B Godoy1, Hanna R Ferreira Dalla Pria1, Mylene T Truong1
1Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 371, Houston, TX 77030, USA.
Abstract:
Fungal pneumonia is the most frequent presentation of invasive fungal infections (IFIs) in patients with hematologic malignancies (HM) and hematopoietic stem cell transplantation (HSCT) recipients. The most common causes include Aspergillus, Mucor, Fusarium, and Candida species. The high incidence and high morbidity and mortality rate of fungal pneumonias in HM/HSCT populations arise from severe immune dysfunction that may be caused by both the underlying disease and/or its treatment. CT is routinely used when pulmonary complications are suspected after HSCT. Appropriate image interpretation of the posttransplant patient requires a combination of pattern recognition and knowledge of the clinical setting. In this article, we provide an overview of the clinical manifestations and CT imaging features of the most common invasive fungal pneumonias (IFPs) seen in severely immunosuppressed hosts.
Insights
Fungal pneumonia is a common, serious complication in patients with hematologic malignancies and after stem cell transplants. This overview details clinical and CT imaging features of invasive fungal pneumonias in these immunocompromised patients.
Area of Science:
- Medical Imaging
- Infectious Diseases
- Hematology
Background:
- Fungal pneumonia is the most common invasive fungal infection (IFI) in hematologic malignancy (HM) and hematopoietic stem cell transplantation (HSCT) patients.
- Severe immune dysfunction in HM/HSCT populations increases susceptibility to IFIs, leading to high morbidity and mortality.
- Common causative agents include Aspergillus, Mucor, Fusarium, and Candida species.
Purpose of the Study:
- To provide an overview of clinical manifestations and CT imaging features of invasive fungal pneumonias (IFPs).
- To aid in the interpretation of pulmonary complications in severely immunosuppressed hosts, particularly post-HSCT.
Main Methods:
- Review of clinical manifestations and computed tomography (CT) imaging features of common IFPs.
- Focus on pattern recognition combined with clinical context for post-HSCT patients.
Main Results:
- Fungal pneumonia presents frequently in HM/HSCT recipients due to profound immune suppression.
- CT is a key diagnostic tool for suspected pulmonary complications post-HSCT.
- Understanding specific imaging patterns is crucial for diagnosis.
Conclusions:
- Invasive fungal pneumonias are a significant threat to HM and HSCT patients.
- Accurate interpretation of CT findings in conjunction with clinical information is essential for timely diagnosis and management.
- This review highlights key imaging features to improve diagnostic accuracy.
More Related Videos
04:37Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...